scholarly journals P354 The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S257-S257
Author(s):  
A. Zand ◽  
E. Aredas ◽  
N. Duran ◽  
C. DiNicola ◽  
P. Lacey ◽  
...  
2017 ◽  
Vol 152 (5) ◽  
pp. S790
Author(s):  
Aria Zand ◽  
Elizabeth Aredas ◽  
Natalie E. Duran ◽  
Courtney A. DiNicola ◽  
Precious Lacey ◽  
...  

2014 ◽  
Vol 20 (10) ◽  
pp. 1747-1753 ◽  
Author(s):  
Welmoed K. van Deen ◽  
Martijn G. H. van Oijen ◽  
Kelly D. Myers ◽  
Adriana Centeno ◽  
William Howard ◽  
...  

2018 ◽  
Vol 1 (1) ◽  
pp. 120-128 ◽  
Author(s):  
Shota Saito ◽  
Kyoko Nakazawa ◽  
Kenji Suzuki ◽  
Takashi Ishikawa ◽  
Kouhei Akazawa

Anti-tumor necrosis factor-α (anti-TNFα) agents are used for induction and maintenance of remission in patients with inflammatory bowel diseases (IBD). However, biologic drugs present a large economic burden on health insurance systems. We aimed to estimate the mean annual health care cost per patient with IBD and cost contribution of anti-TNFα agents. We performed an analysis of patients with Crohn’s disease (CD) and ulcerative colitis (UC) based on a large-scale administrative claims database constructed by Japan Medical Data Center (JMDC) Co. Ltd., comprising inpatient, outpatient, and pharmacy claims data. We evaluated all claims from 1 April 2013 through 31 March 2016. Descriptive statistics were used to measure median health care costs paid per member per year (PMPY) and the relative cost contribution of anti-TNFα agents. A total 1405 patients with CD and 5771 with UC were included. Median costs PMPY were approximately six times higher for CD than UC (JPY 1,957,320 and JPY 278,760, respectively). Medication cost for anti-TNFα agents was the main cost driver, accounting for 59.9% and 17.8% of the total costs for CD and UC, respectively. In Japan, costs for anti-TNFα agents have resulted in drug costs exceeding inpatient costs for IBD. Optimized use of anti-TNFα agents and introduction of biosimilars for anti-TNFα agents can be expected to substantially reduce the health care costs of IBD.


2016 ◽  
Vol 150 (4) ◽  
pp. S70-S71 ◽  
Author(s):  
Welmoed K. van Deen ◽  
Martha Skup ◽  
Adriana Centeno ◽  
Natalie E. Duran ◽  
Precious Lacey ◽  
...  

2020 ◽  
Vol 2 (3) ◽  
Author(s):  
Hilary K Michel ◽  
Nalyn Siripong ◽  
Robert B Noll ◽  
Sandra C Kim

Abstract Background Children with inflammatory bowel diseases (IBDs) require primary and gastrointestinal (GI) care, but little is known about patient and family preferences for care receipt. We aimed to understand caregiver perceptions of current healthcare quality, describe barriers to receiving healthcare, and elicit caregiver and adolescent preferences for how comprehensive care ideally would be delivered. Methods This was an anonymous survey of caregivers of 2- to 17-year olds with IBD and adolescents with IBD aged 13–17 years at a large, free-standing children’s hospital. Surveys assessed patient medical history, family demographics, perceptions of health care quality and delivery, barriers to primary and GI care, and preferences for optimal care delivery. Results Two hundred and seventeen caregivers and 140 adolescents were recruited, 214 caregivers and 133 adolescents consented/assented, and 160 caregivers and 84 adolescents completed the survey (75% and 60% response rate, respectively). Mean patient age was 14 years (SD = 3); 51% male; 79% Crohn’s disease, 16% ulcerative colitis, and 4% indeterminate colitis. Caregivers were primarily female (86%), Caucasian (94%), and living in a 2-caregiver household (79%). Most caregivers reported that their child’s primary care physician (PCP) and GI doctor oversaw their primary care (71%) and their IBD care (94%), respectively. Caregivers were satisfied with communication with their PCP and GI providers (>90%) but did not know how well they communicated with one another (54%). Barriers to primary and GI care varied, and few caregivers (6%) reported unmet healthcare needs. Caregivers and adolescents saw PCPs and GI doctors having important roles in comprehensive care, though specific preferences for care delivery differed. Conclusion Caregivers and adolescent perspectives are essential to developing family-centered care models for children with IBD.


2010 ◽  
Vol 12 (3) ◽  
pp. 273-283 ◽  
Author(s):  
Anne Prenzler ◽  
Bernd Bokemeyer ◽  
J.-Matthias von der Schulenburg ◽  
Thomas Mittendorf

Sign in / Sign up

Export Citation Format

Share Document